SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 25, 1998
CITA BIOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
Colorado 0-109659 93-0962072
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
9025 Wilshire Blvd., Beverly Hills, California 90211
(Address of principal executive office) (Zip Code)
Registrant's telephone number, including area code: (310) 550-4965
N/A
(Former name or former address, if changed since last report)
Item 1. Changes in Control of Registrant
Not Applicable
Item 2. Acquisition or Disposal of Assets
Not Applicable
Item 3. Bankruptcy or Receivership
Not Applicable
Item 4. Changes in Registrant's Certifying Accountant
Not Applicable.
Item 5. Other Events
Effective September 25, 1998, the Registrant changed its fiscal year
end from September 30 to December 31, effective immediately.
Item 6. Resignation of Registrant's Directors
Not Applicable
Item 7. Financial Statements and Exhibits
(a) Financial statements of business acquired.
Not Applicable
(b) Pro forma financial information
Not Applicable
<PAGE>
(c) Exhibits
Not Applicable
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CITA BIOMEDICAL, INC.
By: /s/ Joseph V. Dunn
------------------------------------
Joseph V. Dunn, Chief Executive Officer
Dated as of: September 25, 1998
